Figure S6 from Overcoming Acquired Resistance to AZD9291, A Third-Generation EGFR Inhibitor, through Modulation of MEK/ERK-Dependent Bim and Mcl-1 Degradation
Year: 2023
Type: other
Abstract: The combination of AZD9291 with a MEK inhibitor effectively inhibits the growth of PC-9/3M cells
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362405381
